IgGenix Demonstrated Potential for Single-Cell RNA-Sequencing to Address Shellfish Allergies at the 2023 AAAAI Annual Meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #AAAAI2023--IgGenix recently presented insights into the potential for IgE antibody re-engineering in shellfish allergy at the AAAAI Annual Meeting

Click to view original post